Cargando…
Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
Purpose. To study epidemiology, clinical findings and visual prognosis of patients with Fuchs' Heterochromic Iridocyclitis (FHI). Methods. A retrospective analysis was performed on 158 patients with FHI. Thirty-five patients were observed only once; the remaining 123 had a mean follow-up of 30....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066004/ https://www.ncbi.nlm.nih.gov/pubmed/27781126 http://dx.doi.org/10.1155/2016/1458624 |
_version_ | 1782460405867610112 |
---|---|
author | Accorinti, Massimo Spinucci, Giovanni Pirraglia, Maria Pia Bruschi, Simone Pesci, Francesca Romana Iannetti, Ludovico |
author_facet | Accorinti, Massimo Spinucci, Giovanni Pirraglia, Maria Pia Bruschi, Simone Pesci, Francesca Romana Iannetti, Ludovico |
author_sort | Accorinti, Massimo |
collection | PubMed |
description | Purpose. To study epidemiology, clinical findings and visual prognosis of patients with Fuchs' Heterochromic Iridocyclitis (FHI). Methods. A retrospective analysis was performed on 158 patients with FHI. Thirty-five patients were observed only once; the remaining 123 had a mean follow-up of 30.7 months (50 of them had a mean follow-up of 63.5 months) and in those we assessed complications, medical and surgical treatment, and long-term visual prognosis. Results. Average age at uveitis diagnosis was 27.2 years and 18.3% of patients were children. Blurred vision (54.5%) and floaters (40.5%) were the most frequent presenting symptoms. Small to medium-sized keratic precipitates (95.6%), iris atrophy (86.8%), and vitreous opacities (91.2%) were the most common signs; the prevalence of cataract and IOP increase was 63.5% and 20.1%, respectively, and their incidence was 0.1 and 0.06 eye/year. Significant risk factor for visual loss was IOP increase at presentation (p = 0.02). At final examination 98% of the eye had a visual acuity ≥ 0.6, and topical (p < 0.001) and systemic (p < 0.001) corticosteroids therapy were used less frequently than before referral. Conclusions. FHI has a good visual prognosis, despite the significant incidence of cataract and glaucoma. A correct and prompt diagnosis might avoid unnecessary therapies and provide excellent visual outcomes. |
format | Online Article Text |
id | pubmed-5066004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-50660042016-10-25 Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis Accorinti, Massimo Spinucci, Giovanni Pirraglia, Maria Pia Bruschi, Simone Pesci, Francesca Romana Iannetti, Ludovico J Ophthalmol Research Article Purpose. To study epidemiology, clinical findings and visual prognosis of patients with Fuchs' Heterochromic Iridocyclitis (FHI). Methods. A retrospective analysis was performed on 158 patients with FHI. Thirty-five patients were observed only once; the remaining 123 had a mean follow-up of 30.7 months (50 of them had a mean follow-up of 63.5 months) and in those we assessed complications, medical and surgical treatment, and long-term visual prognosis. Results. Average age at uveitis diagnosis was 27.2 years and 18.3% of patients were children. Blurred vision (54.5%) and floaters (40.5%) were the most frequent presenting symptoms. Small to medium-sized keratic precipitates (95.6%), iris atrophy (86.8%), and vitreous opacities (91.2%) were the most common signs; the prevalence of cataract and IOP increase was 63.5% and 20.1%, respectively, and their incidence was 0.1 and 0.06 eye/year. Significant risk factor for visual loss was IOP increase at presentation (p = 0.02). At final examination 98% of the eye had a visual acuity ≥ 0.6, and topical (p < 0.001) and systemic (p < 0.001) corticosteroids therapy were used less frequently than before referral. Conclusions. FHI has a good visual prognosis, despite the significant incidence of cataract and glaucoma. A correct and prompt diagnosis might avoid unnecessary therapies and provide excellent visual outcomes. Hindawi Publishing Corporation 2016 2016-10-03 /pmc/articles/PMC5066004/ /pubmed/27781126 http://dx.doi.org/10.1155/2016/1458624 Text en Copyright © 2016 Massimo Accorinti et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Accorinti, Massimo Spinucci, Giovanni Pirraglia, Maria Pia Bruschi, Simone Pesci, Francesca Romana Iannetti, Ludovico Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis |
title | Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis |
title_full | Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis |
title_fullStr | Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis |
title_full_unstemmed | Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis |
title_short | Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis |
title_sort | fuchs' heterochromic iridocyclitis in an italian tertiary referral centre: epidemiology, clinical features, and prognosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066004/ https://www.ncbi.nlm.nih.gov/pubmed/27781126 http://dx.doi.org/10.1155/2016/1458624 |
work_keys_str_mv | AT accorintimassimo fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis AT spinuccigiovanni fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis AT pirragliamariapia fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis AT bruschisimone fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis AT pescifrancescaromana fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis AT iannettiludovico fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis |